• No results found

The role of p53.S389 phosphorylation in DNA damage response pathways and tumorigenesis Bruins, W.

N/A
N/A
Protected

Academic year: 2021

Share "The role of p53.S389 phosphorylation in DNA damage response pathways and tumorigenesis Bruins, W."

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

The role of p53.S389 phosphorylation in DNA damage

response pathways and tumorigenesis

Bruins, W.

Citation

Bruins, W. (2007, October 24). The role of p53.S389 phosphorylation in DNA

damage response pathways and tumorigenesis. Department Toxicogenetics,

Medicine / Leiden University Medical Center (LUMC), Leiden University.

Retrieved from https://hdl.handle.net/1887/12389

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral

thesis in the Institutional Repository of the University

of Leiden

Downloaded from: https://hdl.handle.net/1887/12389

Note: To cite this publication please use the final published version (if

applicable).

(2)

The role of p53.S389 phosphorylation in

DNA damage response pathways and tumorigenesis

Proefschrift

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden,

op gezag van Rector Magnificus Prof. Mr. P.F. van der Heijden,

volgens besluit van het College voor Promoties

te verdedigen op woensdag 24 oktober 2007

klokke 15.00 uur

door

Wendy Bruins

geboren te Zwolle in 1977

(3)

Promotiecommissie

Promotor: Prof. Dr. H. van Steeg

Co-promotor: Dr. A. de Vries (Rijksinstituut voor Volksgezondheid en Milieu, Bilthoven)

Referent: Dr. A.G. Jochemsen

Overige leden: Prof. Dr. J.H.J. Hoeijmakers (Erasmus Medisch Centrum, Rotterdam)

Prof. Dr. R. Willemze

Prof. Dr. L.H.F. Mullenders

The research described in this thesis was performed at the Laboratory of Toxicology, Pathology and Genetics (TOX) of the National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands and was financially supported by a grant (RIVM 2000-2352) of the Dutch Cancer Society (KWF), by a grant (1UO1 ES11044) of the National Institutes of Health/National Institute of Environmental Health Sciences (NIH/NIEHS) concerning the Comparative Mouse Genomics Centers Consortium (CMGCC) and by a BSIK grant through the Netherlands Genomics Initiative (NGI) in the context of the BioRange program of the Netherlands Bioinformatics Centre (NBIC).

Cover design: Derrick van Geest

Printed by: Jurriaans Lindenbaum Grafimedia bv, Amsterdam Zuidoost, The Netherlands

The printing of this thesis was financially supported by Stichting Nationaal Fonds tegen Kanker te Amster- dam, Nutricia Nederland B.V., Greiner Bio-One, BD biosciences, the National Institute of Public Health and the Environment (RIVM) and the Leiden University Medical Center (LUMC).

Referenties

GERELATEERDE DOCUMENTEN

with its growing familiarity with the internet. According to the Brazilian Research Media of 2015 13 , the internet is, by far, the fastest spreading medium in the

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded.

Chapter 3 Absence of Ser389 phosphorylation in p53 affects the basal gene-expression level of many p53-dependent genes and alters the biphasic response to UV exposure in

MEFs of the p53.K317R mice showed normal G1/S cell cycle arrest after UV radiation and furthermore no difference in expression levels of p53 target genes (p21, Pidd, Noxa and

Moreover, the effects of the p53.S389A mutation on several known p53-dependent processes, such as transcriptional activation of target genes, apoptosis, and cell cycle arrest,

Analysis of the responses on the transcriptome level of p53.S389A MEFs revealed that this p53.S389 phosphorylation site is involved in both the regulation of basal expression

Om deze doelen te bereiken is in dit onderzoek een vergelijking uitgevoerd van de macrofaunagegevens die aanwezig zijn in de Limnodata Neerlandica met de

Vaak wordt de term voorbehouden aan het klinisch beeld waarbij sprake is van verhoogde cardiale enzymen in het bloed al dan niet in combinatie met afwijkingen op het ECG